Work

Supplementary Methods from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Methods
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361816604
Cites:
Cited by:
Related to: 10